Bristol-Myers Announces European Commission Has Approved Nivolumab BMS in Europe
July 20, 2015 at 12:09 PM EDT
Bristol-Myers Squibb Company (NYSE: BMY) today announced that the European Commission has approved Nivolumab BMS for the treatment of ...